PNTG (Pennant Group) Research & Development: $0 Mil (TTM As of Mar. 2026)


PNTG Pennant Group Inc PNTG
90 GF Score
Price $34.57
GF Value $34.46
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Pennant Group Research & Development?

Pennant Group PNTG +0.99% 90 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates PNTG with a GF Score™ of 90/100 and a GF Value™ of $34.46 (Fairly Valued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Pennant Group's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Pennant Group  (NAS:PNTG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Pennant Group Research & Development Related Terms

Pennant Group Research & Development Historical Data

* Premium members only.

The historical data trend for Pennant Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pennant Group Research & Development Chart

Pennant Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Pennant Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
PNTG
90GF Score
Pennant Group Inc PNTG
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pennant Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Pennant Group (PNTG) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Pennant Group and its competitors.
Is Pennant Group's Research & Development too high?
Pennant Group's current Research & Development is $0 Mil. Overall, Pennant Group has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pennant Group's Research & Development compare to AMN and ARDT?
Pennant Group's Research & Development of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Pennant Group and its competitors. Pennant Group's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pennant Group stock overvalued right now?
Based on GuruFocus' analysis, Pennant Group (PNTG) is currently considered Fairly Valued. The stock's GF Value™ is $34.46, compared to a current price of $34.57 — trading 0.3% above its estimated fair value. The current Research & Development is $0 Mil. Pennant Group's overall GF Score™ is 90/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Pennant Group (PNTG), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pennant Group (PNTG) Overvalued in 2026?

Based on GuruFocus' analysis, Pennant Group stock appears to be overvalued. The current stock price of $34.57 is trading 0.3% above its estimated GF Value™ of $34.46. GuruFocus considers Pennant Group to be Fairly Valued.

Key valuation signals for PNTG:

  • Research & Development: $0 Mil
  • GF Value™: $34.46 vs. price of $34.57 (0.3% above fair value)
  • GF Score™: 90/100 with 8 warning signs

No single metric tells the full story. See the PNTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pennant Group Business Description

Other Exchanges 1ZU:Germany
Address 1675 East Riverside Drive, Suite 150, Eagle, ID, USA, 83616
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
90GF Score

Get the complete analysis for PNTG

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$34.57
Price
$34.46
GF Value